Are you in or out?

While pharma outsourcing is still on the rise, the pandemic has led to near-shoring or activities being brought in-house to ensure milestones could be met. Where will we make our medicines in the future?


MARK TALFORD | Deputy Challenge Director, Medicines Manufacturing | Innovate UK


NATHALIE HUTHER | VP Business Development | Nanoform
CHARLOTTE WILES | Chief Executive Officer | Chemtrix​
REBECCA COUTTS | General Manager | PCI Pharma Services
GARETH JENKINS | Vice President, Science and Technology | Quotient Sciences
DAI HAYWARD MBE | Chief Executive Officer | Micropore Technologies
DECLAN HANNIGAN | Director of Business Planning | SK biotek Ireland an SK pharmteco Company